JBCHEPHARM Stock Overview
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 5/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
J. B. Chemicals & Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,650.40 |
52 Week High | ₹1,940.00 |
52 Week Low | ₹875.00 |
Beta | -0.052 |
1 Month Change | 0.40% |
3 Month Change | 1.59% |
1 Year Change | 68.86% |
3 Year Change | 163.62% |
5 Year Change | 847.82% |
Change since IPO | 2,085.24% |
Recent News & Updates
Recent updates
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Mar 13This Insider Has Just Sold Shares In J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Feb 28What Kind Of Shareholders Hold The Majority In J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Shares?
Feb 26Interested In J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Upcoming ₹8.50 Dividend? You Have Three Days Left
Feb 13Shareholder Returns
JBCHEPHARM | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 1.9% | 2.7% | 2.5% |
1Y | 68.9% | 63.9% | 47.3% |
Return vs Industry: JBCHEPHARM exceeded the Indian Pharmaceuticals industry which returned 63.9% over the past year.
Return vs Market: JBCHEPHARM exceeded the Indian Market which returned 47.3% over the past year.
Price Volatility
JBCHEPHARM volatility | |
---|---|
JBCHEPHARM Average Weekly Movement | 3.7% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.6% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: JBCHEPHARM has not had significant price volatility in the past 3 months.
Volatility Over Time: JBCHEPHARM's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1976 | 5,095 | Nikhil Chopra | https://www.jbpharma.com |
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.
J. B. Chemicals & Pharmaceuticals Limited Fundamentals Summary
JBCHEPHARM fundamental statistics | |
---|---|
Market cap | ₹255.99b |
Earnings (TTM) | ₹5.14b |
Revenue (TTM) | ₹33.85b |
49.8x
P/E Ratio7.6x
P/S RatioIs JBCHEPHARM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
JBCHEPHARM income statement (TTM) | |
---|---|
Revenue | ₹33.85b |
Cost of Revenue | ₹11.85b |
Gross Profit | ₹22.00b |
Other Expenses | ₹16.86b |
Earnings | ₹5.14b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 33.13 |
Gross Margin | 65.00% |
Net Profit Margin | 15.19% |
Debt/Equity Ratio | 16.6% |
How did JBCHEPHARM perform over the long term?
See historical performance and comparison